CoChat

Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl‐terminal fragment of Alzheimer's APP in mice

Choi, Se Hoon, Park, Cheol Hyoung, Koo, Ja Wook, Seo, Ji-Heui, Kim, Hye-Sun, Jeong, Sung-Jin, Lee, Jun-Ho, Kim, Sung Su, Suh, Yoo-Hun · 2001 · The FASEB Journal
Cited by 47

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is characterized by cognitive impairment and excessive deposition of neurite plaques (NPs). Although the pathogenic mechanism of AD is not exactly known, there is increasing evidence that amyloid beta protein (Aβ), which is the major constituent of NPs and is derived from amyloid precursor protein (APP), plays a key role in the neuronal degeneration in AD. However, because there are several discrepancies between Aβ deposition and neurodegeneration or cognitive impairment in AD, the possible effects of other cleavage products of APP need to be explored. We previously showed that a recombinant carboxyl‐terminal 105 amino acid fragment of APP (CT105) induced neurotoxicities both in vitro and in vivo. However, it is unclear whether learning and memory impairments and neurochemical changes are induced by CT 105. To elucidate the in vivo neurotoxicities of Aβ and CT105, we examined behavioral changes using a Y‐maze and a water maze task following a single intracerebroventricular injection of CT105 (68.5, 342 and 685 pmol) or Aβ 1–42 (685 pmol) to mice. We also quantified the changes in the acetylcholine (ACh) level and assayed mitochondrial pyruvate dehydrogenase (PDH) activity. CT105 caused much more significant impairments in cued, spatial, and working memory performances of mice in Y‐maze and water maze tasks in a dose‐dependent manner than Aβ 1–42 . Also, the mice injected with CT105 revealed significant decreases in ACh levels and reduced PDH activities in the cerebral cortex and hippocampus compared with the saline‐treated control and Aβ1–42‐treated groups. These results suggest that learning and memory impairment induced by centrally administered CT105 is in some way related to the reduced ACh levels and mitochondrial PDH activities and that CT105 is more potent than Aβ in inducing cognitive dysfunction.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.00-0859fje

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 54

  1. 10.1002/ana.410140502 · DOI · Paper page
  2. Quirion R., 1993, Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release, J. Psychiatry Neurosci., 18, 226
  3. Palmer A. M., 1990, Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic?, FASEB J., 4, 2745, 10.1096/fasebj.4.10.2165009 · DOI · Paper page
  4. 10.1046/j.1471-4159.1996.67051882.x · DOI · Paper page
  5. 10.1016/S0006-8993(00)02545-2 · DOI
  6. 10.1126/science.2111583 · DOI · Paper page
  7. 10.1046/j.1471-4159.1994.63020781.x · DOI · Paper page
  8. 10.1073/pnas.88.16.7247 · DOI · Paper page
  9. 10.1016/0197-4580(92)90053-Z · DOI · Paper page
  10. 10.1016/0006-8993(94)90193-7 · DOI
  11. 10.1523/JNEUROSCI.12-02-00376.1992 · DOI · Paper page
  12. 10.1073/pnas.90.16.7508 · DOI · Paper page
  13. 10.1016/0306-4522(93)90331-9 · DOI
  14. 10.1016/0197-4580(92)90059-7 · DOI
  15. 10.1016/0006-8993(95)00323-I · DOI
  16. 10.1023/A:1021691918517 · DOI · Paper page
  17. 10.1097/00005072-199301000-00004 · DOI · Paper page
  18. 10.1046/j.1471-4159.1996.66052034.x · DOI
  19. 10.1046/j.1471-4159.2000.741112.x · DOI
  20. 10.1097/00001756-199905140-00008 · DOI
  21. 10.1046/j.1471-4159.1996.67031172.x · DOI
  22. 10.1016/0006-291X(91)91572-T · DOI
  23. 10.1016/0014-5793(94)00851-5 · DOI
  24. 10.1126/science.2474201 · DOI · Paper page
  25. Seubert P., 1993, Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide, Vature, 361, 260
  26. Kim H. S., 2000, Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity, FASEB J., 14, 1508
  27. 10.1046/j.1471-4159.1998.71020875.x · DOI · Paper page
  28. 10.1073/pnas.89.22.10857 · DOI · Paper page
  29. 10.1073/pnas.89.8.3448 · DOI · Paper page
  30. Barelli H., 1997, Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid beta peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases, Mol. Med., 3, 695, 10.1007/BF03401708 · DOI
  31. 10.1038/74656 · DOI · Paper page
  32. 10.1016/0024-3205(94)00853-1 · DOI
  33. 10.1016/0160-5402(86)90038-0 · DOI · Paper page
  34. 10.1007/BF00212843 · DOI · Paper page
  35. 10.1016/0197-4580(94)00155-3 · DOI · Paper page
  36. 10.1111/j.1471-4159.1982.tb04727.x · doi:10.1111/j.1471-4159.1982.tb04727.x
  37. Fulda S., 1988, Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid, J. Biol. Chem., 273, 33942, 10.1074/jbc.273.51.33942 · DOI · Paper page
  38. 10.1016/0896-6273(94)90165-1 · DOI · Paper page
  39. 10.1016/S0169-328X(99)00014-5 · DOI
  40. 10.1097/00001756-199710200-00006 · DOI · Paper page
  41. 10.1016/0006-8993(94)91697-7 · DOI
  42. 10.1046/j.1471-4159.1998.71020723.x · DOI · Paper page
  43. 10.1046/j.1471-4159.1995.64020749.x · DOI · Paper page
  44. Hoshi M., 1996, Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain, Proc.Natl. Acad. Sci. USA, 93, 2719, 10.1073/pnas.93.7.2719 · DOI · Paper page
  45. 10.1002/ana.410130116 · DOI · Paper page
  46. 10.1111/j.1471-4159.1980.tb12511.x · DOI
  47. 10.1016/0304-3940(80)90220-7 · DOI · Paper page
  48. 10.1111/j.1471-4159.1981.tb10817.x · doi:10.1111/j.1471-4159.1981.tb10817.x
  49. 10.1016/0304-3940(95)12058-C · DOI
  50. 10.1126/science.7058341 · DOI · Paper page
  51. 10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO;2-I · DOI
  52. 10.1016/0006-291X(92)91730-E · DOI
  53. 10.1073/pnas.85.19.7341 · DOI · Paper page
  54. 10.1073/pnas.89.4.1345 · DOI · Paper page

Cited by

See all 47

Metadata

Authors
Choi, S. H., Park, C. H., Koo, J. W., Seo, J.-H., Kim, H.-S., Jeong, S.-J., Lee, J.-H., Kim, S. S., & Suh, Y.-H.
Venue
The FASEB Journal
Publisher
Wiley
Published
2001-06-18
Volume
15
Issue
10
Pages
1816-1818
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2122424729
Cited by
47
References
2
FWCI
1.11
Type
journal article
Language
en
Open access
closed
Funders
  • Ministry of Science and Technology (HMP-98-N-6-0002)
  • Ministry of Health and Welfare (HMP-98-N-6-0002)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl‐terminal fragment of Alzheimer's APP in mice. https://app.cochat.ai/papers/10.1096/fj.00-0859fje
The paper
Choi, S. H., Park, C. H., Koo, J. W., Seo, J.-H., Kim, H.-S., Jeong, S.-J., Lee, J.-H., Kim, S. S., & Suh, Y.-H. (2001). Memory impairment and cholinergic dysfunction by centrally administered Aβ and carboxyl‐terminal fragment of Alzheimer's APP in mice. The FASEB Journal. https://doi.org/10.1096/fj.00-0859fje

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.